Johnson & Johnson (JNJ) begins on Tuesday its third attempt to push through a multi-billion-dollar settlement relating to ...
Bright Futures Wealth Management LLC. cut its holdings in Johnson & Johnson (NYSE:JNJ – Free Report) by 55.1% in the 4th ...
In a report released today, Josh Jennings from TD Cowen maintained a Buy rating on Johnson & Johnson (JNJ – Research Report), with a price ...
Blue Trust Inc. lifted its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 28.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities ...
Johnson & Johnson is well-diversified across thriving healthcare segments, with promising FDA approvals. Read why I assign a ...
Regeneron initiated a quarterly dividend per share that looks somewhat attractive. Despite some recent issues, the biotech ...
European defense stocks continued their steep upward trend as U.S. and Russian officials held talks in Saudi Arabia on improving bilateral relations and potentially halting Ukraine war, and hours ...
14h
Hosted on MSNISRG Nears $600: Can the Stock Breach the Mark Again This Month?Shares of Intuitive Surgical ISRG breached $600 on Jan. 21 but failed to sustain the level. The stock price fell below the ...
Learn the differences between old economy stocks that represent large, established companies and new economy stocks such as tech companies.
Despite this growth, the broader trend for the electric vehicle (EV) manufacturer in China is raising concerns among analysts ...
Genmab's Q4 2024 results impress with $897.4M revenue and 29% growth. GMAB's balance sheet is strong with nearly $3 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results